L. Neipp

855 total citations
33 papers, 621 citations indexed

About

L. Neipp is a scholar working on Organic Chemistry, Pharmacology and Molecular Biology. According to data from OpenAlex, L. Neipp has authored 33 papers receiving a total of 621 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Organic Chemistry, 13 papers in Pharmacology and 12 papers in Molecular Biology. Recurrent topics in L. Neipp's work include Microbial Natural Products and Biosynthesis (13 papers), Synthetic Organic Chemistry Methods (9 papers) and Chemical Synthesis and Analysis (5 papers). L. Neipp is often cited by papers focused on Microbial Natural Products and Biosynthesis (13 papers), Synthetic Organic Chemistry Methods (9 papers) and Chemical Synthesis and Analysis (5 papers). L. Neipp collaborates with scholars based in Switzerland and Germany. L. Neipp's co-authors include E. Gäumann, W. Keller‐Schierlein, Hans Zähner, L. Ettlinger, F. Kradolfer, V. Prelog, R. Corbaz, P Reusser, R. Hütter and R. Meier and has published in prestigious journals such as Annals of the New York Academy of Sciences, Cellular and Molecular Life Sciences and Helvetica Chimica Acta.

In The Last Decade

L. Neipp

31 papers receiving 518 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
L. Neipp Switzerland 14 290 277 277 68 41 33 621
Hiroshi Tsukiura United Kingdom 13 167 0.6× 238 0.9× 187 0.7× 35 0.5× 47 1.1× 29 402
J. Philip Poyser United Kingdom 12 194 0.7× 258 0.9× 156 0.6× 87 1.3× 65 1.6× 22 522
Norio Ezaki United Kingdom 15 218 0.8× 212 0.8× 247 0.9× 49 0.7× 53 1.3× 25 503
R. Corbaz Switzerland 13 167 0.6× 241 0.9× 232 0.8× 56 0.8× 135 3.3× 35 577
K. Eckardt Germany 16 307 1.1× 370 1.3× 395 1.4× 118 1.7× 83 2.0× 74 727
J. A. Mabe United States 13 140 0.5× 300 1.1× 204 0.7× 55 0.8× 93 2.3× 25 534
W. Pache Germany 7 110 0.4× 264 1.0× 163 0.6× 57 0.8× 65 1.6× 9 482
Ronald R. Rasmussen United Kingdom 13 259 0.9× 238 0.9× 185 0.7× 57 0.8× 30 0.7× 21 488
LaVerne D. Boeck United States 13 251 0.9× 414 1.5× 323 1.2× 109 1.6× 47 1.1× 16 689
Hiroo Kusakabe Japan 13 318 1.1× 365 1.3× 189 0.7× 56 0.8× 37 0.9× 26 611

Countries citing papers authored by L. Neipp

Since Specialization
Citations

This map shows the geographic impact of L. Neipp's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by L. Neipp with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites L. Neipp more than expected).

Fields of papers citing papers by L. Neipp

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by L. Neipp. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by L. Neipp. The network helps show where L. Neipp may publish in the future.

Co-authorship network of co-authors of L. Neipp

This figure shows the co-authorship network connecting the top 25 collaborators of L. Neipp. A scholar is included among the top collaborators of L. Neipp based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with L. Neipp. L. Neipp is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jaques, R., et al.. (1967). Ein chemisch und pharmakologisch neuartiger Antagonist von pathophysiologisch bedeutsamen Aminen, Kininen und kininbildenden Faktoren. Cellular and Molecular Life Sciences. 23(2). 149–150. 7 indexed citations
2.
Kradolfer, F., et al.. (1966). Chemotherapeutic activity of new derivatives of rifamycin.. PubMed. 6. 359–64. 5 indexed citations
3.
Keller‐Schierlein, W., et al.. (1963). [METABOLITES OF MICROORGANISMS. 41. MANUMYCIN].. PubMed. 38. 871–4. 24 indexed citations
4.
Reusser, P, et al.. (1962). Ferrimycin A, a new iron-containing antibiotic.. PubMed. 12. 34–45. 13 indexed citations
5.
Gäumann, E., R. Hütter, W. Keller‐Schierlein, et al.. (1960). Stoffwechselprodukte von Actinomyceten. 21. Mitteilung. Lankamycin und Lankacidin. Helvetica Chimica Acta. 43(2). 601–606. 60 indexed citations
6.
Ettlinger, L., E. Gäumann, R. Hütter, et al.. (1959). Stoffwechselprodukte von Actinomyceten 17. MitteilungHolomycin. Helvetica Chimica Acta. 42(2). 563–569. 52 indexed citations
7.
Neipp, L., Werner Kunz, & R. Meier. (1959). Relations du « métabolisme respiratoire » des bactéries et du type de bactériophage avec l'activité de substances antiphages. Cellular and Molecular Life Sciences. 15(7). 258–260. 1 indexed citations
8.
Neipp, L., et al.. (1958). [Experimental studies with new sulfonamide derivatives with special reference to relations between blood concentration, intensity and duration of effect].. PubMed. 88(34). 835–9 contd. 4 indexed citations
9.
Kradolfer, F. & L. Neipp. (1958). Experimental studies on amebicidal, antibacterial, and antiparasitic phenanthroline compounds.. PubMed. 8(6). 297–308. 4 indexed citations
10.
Neipp, L., et al.. (1958). [Experimental investigations of the new sulfonamide derivatives with special reference to the relations between blood concentrations, intensity and duration of therapeutic effect].. PubMed. 88(35). 858–63 concl. 1 indexed citations
11.
Corbaz, R., L. Ettlinger, E. Gäumann, et al.. (1957). Stoffwechselprodukte von Actinomyceten. 7. Mitteilung. Echinomycin. Helvetica Chimica Acta. 40(1). 199–204. 77 indexed citations
12.
Ettlinger, L., R. H�tter, W. Keller‐Schierlein, et al.. (1957). Stoffwechselprodukte von Actinomyceten. Monatshefte für Chemie - Chemical Monthly. 88(5). 989–995. 8 indexed citations
13.
Neipp, L., et al.. (1957). EXPERIMENTAL ACTIVITIES OF NEW SULFONAMIDES. Annals of the New York Academy of Sciences. 69(3). 448–456. 5 indexed citations
14.
Neipp, L., Werner Kunz, & R. Meier. (1957). Spécificité de l'action antiphage de substances synthétiques. Cellular and Molecular Life Sciences. 13(2). 74–75. 7 indexed citations
15.
Neipp, L.. (1957). Action du propylène-glycol et d’autres substances à fonction alcool sur l’activité antibactérienne. Pathobiology. 20(2). 150–160. 2 indexed citations
16.
Neipp, L., et al.. (1956). [An attempt to analyze direct and indirect antiphagocytic action].. PubMed. 19(3). 331–50. 1 indexed citations
17.
Meier, R. & L. Neipp. (1956). [Strengthening the chemotherapeutic effect of sulfohamides with chemotactic polysaccharides from urine and bacteria].. PubMed. 86(10). 249–51. 5 indexed citations
18.
Corbaz, R., L. Ettlinger, E. Gäumann, et al.. (1955). Stoffwechselprodukte von Actinomyceten. 2. Mitteilung. Angolamycin. Helvetica Chimica Acta. 38(5). 1202–1209. 17 indexed citations
19.
Corbaz, R., L. Ettlinger, E. Gäumann, et al.. (1955). Stoffwechselprodukte von Actinomyceten. 3. Mitteilung. Nonactin. Helvetica Chimica Acta. 38(6). 1445–1448. 74 indexed citations
20.
Meier, R., et al.. (1954). Die Wirkung von Demecolceinamiden an Zellenin vitro. Cellular and Molecular Life Sciences. 10(2). 74–76. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026